Galectin Therapeutics Inc (GALT)
NASDAQ:GALT

Galectin Therapeutics (GALT) Balance Sheet

552 Followers

Galectin Therapeutics Balance Sheet

Galectin Therapeutics's total assets for Q1 2024 were $25.89M, a decrease of -8.19% from the previous quarter. GALT total liabilities were $96.98M for the fiscal quarter, a 9.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 28.20M$ 21.29M$ 41.83M$ 29.60M$ 48.47M
Total Liabilities
$ 88.44M$ 53.48M$ 39.21M$ 5.41M$ 2.87M
Total Equity Gross Minority
$ -61.96M$ -33.92M$ 893.00K$ 24.19M$ 45.59M
Total Capitalization
$ -61.96M$ -33.92M$ 893.00K$ 24.19M$ 45.59M
Preferred Stock Equity
---$ 2.25M$ 2.26M
Capital Lease Obligations
---$ 44.00K$ 39.00K
Currency in USD

Galectin Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis